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Background: Obesity is characterized by a chronic low-grade inflammation and altered stress responses in key
metabolic tissues. Impairment of heat shock response (HSR) has been already linked to diabetes and insulin resistance
as reflected by decrease in heat shock proteins (HSPs) expression. However, the status of HSR in non-diabetic human
obese has not yet been elucidated. The aim of the current study was to investigate whether obesity triggers a change
in the HSR pattern and the impact of physical exercise on this pattern at protein and mRNA levels.
Methods: Two groups of adult non-diabetic human subjects consisting of lean and obese (n = 47 for each group) were
enrolled in this study. The expression pattern of HSP-27, DNAJB3/HSP-40, HSP-60, HSC-70, HSP72, HSP-90 and GRP-94 in
the adipose tissue was primarily investigated by immunohistochemistry and then complemented by western blot and
qRT-PCR in Peripheral blood mononuclear cells (PBMCs). HSPs expression levels were correlated with various physical,
clinical and biochemical parameters. We have also explored the effect of a 3-month moderate physical exercise on the
HSPs expression pattern in obese subjects.
Results: Obese subjects displayed increased expression of HSP-60, HSC-70, HSP-72, HSP-90 and GRP-94 and lower
expression of DNAJB3/HSP-40 (P < 0.05). No differential expression was observed for HSP-27 between the two groups.
Higher levels of HSP-72 and GRP-94 proteins correlated positively with the indices of obesity (body mass index and
percent body fat) and circulating levels of IFN-gamma-inducible protein 10 (IP-10) and RANTES chemokines. This
expression pattern was concomitant with increased inflammatory response in the adipose tissue as monitored by
increased levels of Interleukin-6 (IL-6), Tumor necrosis factor-α (TNF-α), and RANTES (P < 0.05). Physical exercise reduced
the expression of various HSPs in obese to normal levels observed in lean subjects with a parallel decrease in the
endogenous levels of IL-6, TNF-α, and RANTES.
Conclusion: Taken together, these data indicate that obesity triggers differential regulation of various components
of the HSR in non-diabetic subjects and a 3-month physical moderate exercise was sufficient to restore the normal
expression of HSPs in the adipose tissue with concomitant attenuation in the inflammatory response.
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Obesity has become a major medical, social and eco-
nomic burden worldwide by reducing both life quality
and expectancy [1,2]. It also represents a major risk fac-
tor for various health disorders including insulin resist-
ance, diabetes, hypertension and cardiovascular diseases
(CVD). As physical inactivity, sedentary lifestyle and in-
creased energy intake are key contributing factors to
obesity, healthy diet and regular exercise are usually pre-
scribed as a first line non-medical therapy to control
obesity-related complications [3].
Obesity is characterized by a chronic, low-grade inflam-
mation and an impaired intracellular stress defence system
in key metabolic tissues including muscles, adipose tissue
and liver [4]. While obesity-induced inflammation de-
pends on a set of classical inflammatory mediators, the
stress response is more complex and includes an impair-
ment of the heat shock response (HSR) [5,6], excessive ac-
tivation of the oxidative stress along with down-regulation
of the cellular antioxidant defense system [7], dysfunction
of the mitochondria [8], and the endoplasmic reticulum
(ER)-mediated stress [4].
HSR is one of the important cellular endogenous com-
ponents that allow the body to cope with stressful condi-
tions including metabolic stress [9,10]. This response
involves a set of highly conserved proteins called Heat
shock proteins (HSPs) known also as molecular chaper-
ones, glucose regulated proteins (GRPs) and other pro-
teins essential for protection and recovery from tissue
damage [11-13].
Intracellular HSPs execute their tasks by binding non-
covalently to misfolded, aggregated and nascent proteins
and either assist in their proper folding, solubility and
their appropriate translocation or alternatively, eliminate
them through the degradation pathway [13]. HSPs can
also be released into the circulation and exert an immune-
stimulatory effect by interacting with pattern recognition
receptors, such as toll-like receptors, and thereby activate
the host inflammatory response [14,15]. In mammalian
cells, several families of HSPs with distinct functional clas-
ses have been described to date and they consist of HSP-
110, HSP-90, HSP-70, HSP-60, HSP-40, HSP-27 and the
small HSPs [16].
The best characterized heat shock protein is HSP-72,
the inducible member of the HSP-70 family and its role in
insulin resistance was recently a subject of intense investi-
gations. Indeed, HSP-72, was shown to be associated with
insulin resistance as its expression was reduced in type 2
diabetic patients [5,6] and this observations was confirmed
in cellular and animal models [17,18]. Reduced expression
of intracellular HSPs was also linked to CVD and meta-
bolic syndrome, two chronic conditions that are compli-
cated by obesity and diabetes [19,20]. Other studies
reported attenuated cardio-protective role of HSPs withaging factor as this latter is well known to decrease the ex-
pression of HSPs [21,22]. By contrast to the protective role
of intracellular HSPs, increased levels of circulating
HSP-60 were founded in patients with acute myocardial
infarction (AMI) and as such, HSP-60 was suggested as
predictive marker of post-AMI adverse events [23,24].
The importance of the HSR against these chronic con-
ditions was subsequently confirmed by using interven-
tions that induce the HSR and showing a concomitant
improvement of the clinical outcomes. These interven-
tions include heat therapy [18,25] or electrical therapy
[26], physical exercise [26], using pharmacological mole-
cules that stimulate the heat shock response [10,27,28].
Based on these evidences, it was suggested that increas-
ing HSPs expression could be considered a therapeutic
strategy to protect from insulin resistance, diabetes and
to reinforce vascular defense and delay or avoid clinical
complications associated with CVD. While our know-
ledge on the mechanisms and the contribution of HSPs
is well documented for other conditions, little is known
about their dysregulation during the course of obesity,
particularly in non-diabetic subjects.
In the current study, we investigated the expression
levels of various HSPs in non-diabetic human adult
obese and the impact of a 3-month moderate physical
exercise on the expression of those proteins. Our results
have shown that HSPs expression levels were increased
in non-diabetic obese as compared to lean control sub-
jects. Physical exercise, however, has normalized their
levels in most cases. This suggests that, in non-diabetic
obese, the HSR in human body is still coping with the
obesity-related stress.Material and methods
Study population
The study was conducted on adult non-diabetic male
and female subjects consisting of 47 lean (20 ≤ BMI <
25 kg/m2) and 47 obese (30 ≤ BMI < 40 kg/m2). Informed
written consent was obtained from all subjects before
their participation in the study which was approved by
the Review Board of Dasman Diabetes Institute (RA2010-
003) and carried out in line with the guideline ethical
declaration of Helsinki. Participants that followed any
physical exercise within the last 6 months prior to this
study, with prior major illness or intake of medications
and/or supplements known to influence the body com-
position or bone mass were excluded from the study.
White Blood Cell count (WBC) was performed for all
enrolled subjects to ensure the absence of any recent in-
flammation due to pathogens or inflammatory diseases.
The physical, clinical and biochemical characteristics of
the participating subjects are shown in Table 1. The data
on HSP-72 in obese subjects prompted us to add 10
Table 1 Physical, clinical and biochemical characteristics
of the subjects at baseline
Lean (n = 47) Obese (n = 47) P-value
Physical and Clinical characteristics
AGE (year) 38.0 ± 9.4 39.1 ± 8.3 0.51
Gender (M/F) 20/27 23/24 0.44
BMI (kg/m2) 22.60 ± 1.97 34.95 ± 2.93 <0.0001
Weight (kg) 62.02 ± 10.32 96.36 ± 14.71 <0.0001
Height (m) 1.65 ± 0.10 1.66 ± 0.11 0.77
PBF (%) 27.43 ± 5.23 39.29 ± 4.98 <0.0001
SLM (Kg) 42.03 ± 9.29 53.66 ± 11.09 0.0002
Waist (cm) 79.39 ± 15.59 108.61 ± 13.20 <0.0001
Hip (cm) 92.29 ± 14.67 118.55 ± 8.27 <0.0001
Resting HR (beat/min) 80.71 ± 14.51 77.43 ± 8.15 0.73
SBP (mmHg) 113.00 ± 10.81 127.50 ± 11.89 0.01
DBP (mmHg) 76.43 ± 6.33 82.00 ± 10.14 0.13
VO2 Max (ml/kg/min) 21.63 ± 3.76 17.48 ± 4.83 0.03
Metabolic markers
Cholesterol (mmol/l) 5.14 ± 0.90 5.26 ± 0.98 0.22
HDL (mmol/l) 1.47 ± 0.50 1.11 ± 0.25 <0.0001
LDL (mmol/l) 3.18 ± 0.88 3.41 ± 0.94 0.09
TG (mmol/l) 0.90 ± 0.43 1.57 ± 0.93 <0.0001
Glucose (mmol/l) 4.96 ± 0.53 5.40 ± 0.85 0.013
HBA1C (%) 5.47 ± 0.42 5.91 ± 1.11 0.0006
C-peptide (ng/ml) 2.59 ± 0.71 3.08 ± 1.35 0.04
Glucagon (ng/ml) 0.65 ± 0.11 0.71 ± 0.15 0.05
GLP-1 (ng/ml) 2.62 ± 0.83 2.68 ± 1.54 0.96
Insulin (ng/ml) 2.54 ± 1.06 4.51 ± 2.11 0.003
Leptin (ng/ml) 5.25 ± 2.95 8.41 ± 4.39 0.0004
PAI-1 (ng/ml) 3.19 ± 1.55 4.15 ± 1.53 0.015
Inflammatory markers
TNF-α (pg/ml) 24.07 ± 8.30 28.94 ± 14.23 0.96
IL-1β (pg/ml) 1.20 ± 0.47 1.35 ± 0.85 0.89
IL-6 (pg/ml) 5.29 ± 2.02 4.97 ± 2.32 0.37
IL-10 (pg/ml) 1.97 ± 2.00 2.53 ± 2.84 0.87
IP-10 (pg/ml) 365 ± 139 556 ± 224 0.0002
MCP-1 (pg/ml) 9.06 ± 2.73 10.20 ± 4.41 0.89
MIP-1a (pg/ml) 6.93 ± 3.54 10.74 ± 6.08 0.04
RANTES (ng/ml) 1.32 ± 0.68 1.78 ± 0.77 0.01
Oxidative stress markers
ROS (mM) 1.41 ± 0.28 1.51 ± 0.15 0.35
TBARS (μM) 1.18 ± 0.54 1.53 ± 0.49 0.20
Data are presented as mean ± SD. Non-parametric Mann–Whitney test was
used to determine significance of difference in means between lean and
obese groups.
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sion levels of HSP-72 in obese with and without
diabetes.Exercise protocol and anthropometric measurements
All eligible subjects were enrolled to a supervised exer-
cise program at the Fitness and Rehabilitation Center
(FRC) of Dasman Diabetes Institute. Prior to exercise
prescription, each individual underwent a symptom-
limited maximal incremental cardiopulmonary exercise
test “CPET” using an electromagnetically braked cycle
ergometer (COSMED Quark, Italy). The CPET was pri-
marily used to determine the maximum heart rate (max
HR) as well as the response to aerobic exercise as mea-
sured by the maximum oxygen consumption (VO₂ Max)
for each subject. The exercise training involves a com-
bination of both moderate intensity of aerobic exercise
and resistance training using either treadmill or cycling.
Each exercise session includes 10 minutes warming-up
and cooling down steps at 50-60% of max HR, along
with 40 minutes of the prescribed exercise program at
65-80% of max HR. For the duration of the 3-month
period, participants exercised 3 to 5 times per week and
they were instructed to reach and maintain the recom-
mended heart rate range. This was achieved by regular
monitoring of the heart rate during the aerobic training.
Strength training was performed 2 to 3 times a week ac-
cording to the program plan. Exercise intensity, dur-
ation and blood pressures were recorded for each
session. All trainings were supervised by qualified fit-
ness professionals from FRC. To assess the effectiveness
of the exercise, the same, previously mentioned, physical
stress and fitness tests were performed for all subjects at
the end of the exercise program. Anthropometric mea-
surements were taken at the baseline and after 3 months
of exercise. Whole-body composition including body fat
percent was determined by dual-energy radiographic
absorptiometry device (Lunar DPX, Lunar radiation,
Madison, WI).Blood and tissue sampling
Venous peripheral blood and subcutaneous adipose tis-
sue biopsies were obtained before (baseline) and after
3 months of exercise. PBMCs were prepared from blood
using Ficoll-Hypaque density gradient centrifugation
method. Plasma and serum were prepared using vacutai-
ner tubes and then aliquoted and stored at −80°C. Sub-
cutaneous superficial adipose tissue biopsies (~200 mg)
were obtained from the periumbilical area by surgical bi-
opsy after a local anesthesia. Once removed, the biopsy
was rinsed in cold PBS, divided into 4 pieces and stored
appropriately until assayed.
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Glucose, lipid profiles and HbA1c were measured in our
clinical laboratory using standard clinical kits. Plasma
levels of inflammatory and metabolic markers were mea-
sured with bead-based multiplex immunoassays and the
Bio-Plex®-200 system (BioRad, Hercules, CA). This tech-
nology is based on the use of distinctly color-coded
beads that can be conjugated with specific antibodies
allowing simultaneous quantification of up to 100 differ-
ent analytes in the same reaction. To measure the levels
of inflammatory and metabolic markers, we used the hu-
man cytokine 27-plex panel kit and the human 12-plex
diabetes kits, respectively (BioRad, Hercules, CA). A dual
detection flow cytometer is used to sort out the different
assays by bead colors in one channel and determine the
analyte concentration by measuring the reporter dye
fluorescence in another channel. Standard curves for each
analyte were generated using the pre-mixed standards
provided in the kits. The concentration of each analyte
in each sample was determined from the appropriate
standard curve using a 5 point-regression to transform
mean fluorescence intensities into concentrations. Lipid
peroxidation was assessed by measuring plasma levels of
malonaldehyde, using TBARs Assay Kit (Cayman Chemical
Company, Ann Arbor, MI). Serum levels of ROS were de-
termined using the OxiSelect™ ROS Assay Kit (Cell Biolabs
Inc, San Diego, CA). All the above assays were carried out
according to the instructions of the manufacturers.
Immunohistochemistry (IHC)
Formalin fixed, paraffin embedded adipose tissue sam-
ples were prepared and used to make sections for IHC
studies as described previously [29]. Briefly, sections
were deparaffinized and the antigens were retrieved at
high-temperature using antigen unmasking solution
(Dako, Glostrup, Denmark). The endogenous peroxidase
was quenched using 3% H2O2 (Merck, Schuchardt,
Gemany) for 30 min at room temperature (RT). Sections
were blocked with 5% fat-free milk for 1 h at RT
followed by 1% BSA for 1 h and then, incubated at 4°C
for overnight with the corresponding primary antibodies.
After washing, sections were stained with horseradish
conjugated secondary antibody (Dako, Glostrup, Denmark)
for 1 h at RT. Colors were developed using DAB kit (Dako,
Glostrup, Denmark) and sections were counterstained
with hematoxylin (Sigma Aldrich, St. Louis, MO). The
primary antibodies used in IHC were raised against
HSP-27, HSP-60, and HSP-72 (Enzo LifeSciences. Inc,
Lausen, Switzerland), HSC-70, HSP-90, and GRP-94
(Cell Signaling Technology Inc., Danvers, MA), and
DNAJB3/HSP-40 (Proteintech Group. Inc, Chicago, IL).
Negative controls were performed by omitting the ap-
plication of primary antibodies. Biopsies from breast
cancer, kidney cancer, colon, testis and prostate wereused as positive controls for IHC as recommended by
the manufacturers.
Samples from lean, obese before and after exercise were
stained and analyzed within the same batch. For each
slide, a series of 3 images were generated from different
areas of the tissue section under an objective magnifica-
tion of 20x. The quantification of the IHC data was done
using ImageScope software version 11.1 (Aperio, Vista,
CA). The algorithm Positive Pixel Count v9 of this soft-
ware provided the percentage of positive staining (num-
ber of stained pixels) as compared to the whole image
area. Then, each annotated picture was manually checked
against the original slide picture to ensure the correct
matching between the positive staining and the software
annotation. Finally, the staining analysis results of the 3
images obtained from each tissue section were averaged.
Quantitative real time-PCR (qRT-PCR)
Total RNA was extracted from frozen PBMCs using All-
Prep RNA/Protein Kit (Qiagen, Inc., Valencia, CA). The
cDNA was synthesized from total RNA sample using
High Capacity cDNA Reverse Transcription Kits (Applied
Biosystems, Foster City, CA). qRT-PCR was performed on
Rotor gene Q-100 system using SYBR Green normalized
to GAPDH (Qiagen, Inc., Valencia, CA). Relative gene ex-
pression between the groups was assessed by using the
ΔΔCT method [30] and GAPDH as internal control for
normalization. The primers used in this study are summa-
rized in Additional file 1: Table S1.
Western blot analysis
Western blots were carried out on whole PBMC extracts
prepared in RIPA buffer (50 mM Tris–HCl pH 7.5,
150 mM NaCl, 1 mM EDTA, 1% Triton ×100, 0.5%
Sodium deoxycholate, 0.1% SDS and supplemented with
a mini complete protease inhibitor cocktail (Roche
Diagnostics, Laval, Quebec). Protein concentration was
determined by Bradford method using globulin as a
standard. For Western blot, 20 μg of proteins were
resolved on 10% or 12% SDS-PAGE gels. Proteins were
then transferred onto PVDF membranes, blocked with
5% non-fat dried milk in Tris-buffered saline containing
0.05% Tween 20 (TBST) for 1 h at RT and then probed
with the primary antibody for overnight at 4°C. After
washing, the membranes were incubated with horseradish
peroxidase-conjugated secondary antibody for 2 h at RT.
Finally, protein bands were visualized by chemilumines-
cence and the images were captured by using the Versadoc
5000 system (BioRad, Hercules, CA). Primary antibodies
used here were the same mentioned in the IHC section.
Actin (Santa Cruz Biotechnology, Santa Cruz, CA) was
used as internal controls. For densitometric analysis, the
intensity of the bands was determined using Quantity One
Software (BioRad, Hercules, CA).
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Statistical analyses were performed with SAS version 9.2
(SAS Institute Inc, Cary, NC). Unless otherwise stated,
all descriptive statistics for the variables in the study were
reported as means ± standard error. Non-parametric
Mann–Whitney test was used to determine significance of
difference in means between the lean and obese groups
before exercise. Paired t-test was used to determine sig-
nificance of difference in means between the obese group
before and after exercise. Correlations between variables
were calculated with the Spearman’s rank correlation test.
Differences were considered statistically significant at P-
values less than 0.05.Results
Baseline characteristics of the study population
In this study, we selected non diabetic subjects consist-
ing of 47 obese (23 males and 24 females) and 47 age-
matched lean (20 males and 27 females) from our cohort
study. The physical, clinical and biochemical characteris-
tics of the study population at baseline are summarized
in Table 1. As expected, body mass index (BMI), percent
body fat (PBF), waist and hip circumferences were all
significantly higher in obese than in the control subjects
(P < 0.0001). Obese subjects had also higher systolic
blood pressure (P = 0.01) but lower maximal oxygen
consumption (VO2 Max; P = 0.03). HDL levels were sig-
nificantly lower in obese (P < 0.0001) whereas TG levels
were higher in those subjects (P < 0.0001). Although the
study population is not diabetic, obese subjects had
higher glucose and HbA1c levels (P = 0.013 and P =
0.0006; respectively). Likewise, the levels of C-peptide,
Glucagon and insulin were higher in obese subjects
(P < 0.05). The levels of leptin and PAI-1 were also
higher in obese subjects (P = 0.0004 and P = 0.015; re-
spectively). Obese subjects had increased inflammatory
response as monitored by the inflammatory chemokines
IP-10, MIP-1a and RANTES (P = 0.0002, P = 0.04 and
P = 0.01; respectively) but there was no significant differ-
ence in the plasma levels of the classic inflammatory
markers IL-6 and TNF-α between lean and obese
groups. However, the endogenous expression of IL-6 and
TNF-α protein and mRNA in the adipose tissue were
significantly increased in obese subjects (Figure 1). There
was also no significant difference between the two
groups in the levels of oxidative stress markers ROS and
TBARS (Table 1).Obesity triggers differential expression pattern of
components of the heat shock response
To investigate the expression levels of various compo-
nents of the heat shock response between lean and obese
groups we initially used the subcutaneous adipose tissueto determine the expression pattern of seven HSPs at
the protein level by immunohistochemistry (IHC). As
shown in Figure 2A, there was more than 1.5-fold in-
crease in the expression of HSP-60, HSC-70 HSP-72,
HSP-90 and GRP-94 in obese group compared to lean
group (n = 10 for each group; P < 0.05). By contrast, the
expression of DNAJB3 was significantly reduced in obese
group (Figure 2A; P = 0.009) and this was consistent
with our previous finding [31]. The levels of HSP-27
remained however unchanged between the two groups
(Figure 2A). As the amount of adipose tissue biopsies
were limited to prepare whole tissue lysate for Western
blot to validate the IHC data, we prepared whole cell ly-
sates from PBMCs of lean and obese subjects (n = 9 for
each group) and used them for Western blot analyses.
Figure 2B confirmed the findings of the IHC study, i.e.,
no change in the expression levels of HSP-27 between
the two groups, a significant increase in the expression
of HSP-60, HSC-70, HSP-72, HSP-90 and GRP-94 in
obese group (P < 0.05) and a decrease in the levels of
DNAJB3 in obese group (P = 0.023). These data have
been further validated at the mRNA levels in PBMCs by
qRT-PCR that showed a similar trend of increase and
decrease in the expression of various HSPs (Figure 2C).
Defect in the heat shock response in diabetic condi-
tions is an established fact both in humans and animals
in particular for HSP-72 protein [5,6,18]. The unex-
pected increase in the expression of HSP-72 in obese
subjects prompted us carry out a comparison in the ex-
pression levels of HSP-72 protein in 10 diabetic obese
using the adipose tissue. As expected, HSP-72 protein
expression levels were significantly attenuated in this
diabetic group as compared to non-diabetic obese sub-
jects (data not shown).Correlation analysis
In an attempt to understand the relationship between
the levels of HSPs in the adipose tissue and various
physical, clinical and biochemical parameters of our
study population at baseline, we used Spearman’s rank
test for correlation analysis. The most significant corre-
lations were observed for DNAJB3, HSP-72 and GRP-94
as illustrated in Figure 3. Accordingly, there was a nega-
tive correlation between DNAJB3 levels with BMI, PBF
and circulating levels of the inflammatory chemokine
IP-10 (Figures 3A, B and C; P < 0.05). By contrast, both
HSP-72 and GRP-94 levels correlated positively with
BMI and PBF (Figure 3E, F, I and J, respectively; P < 0.05).
Likewise, higher levels of HSP-72 and GRP-94 corre-
lated positively with the circulating levels of both IP-10
and RANTES inflammatory chemokines (Figure 3G, H,
K and L, respectively; P < 0.05). A similar but separated
analysis of the mRNA levels of the HSPs confirmed
A B
Figure 1 Inflammation markers increase in the adipose tissue of obese subjects. Analysis of IL-6 (A) and TNF-α (B) expression by IHC using
the subcutaneous adipose tissue from lean (n = 10) and obese (n = 10) non-diabetic participants. Aperio software was used to quantify positive
staining (indicated by arrows on the IHC slides) as detailed in Material and Methods section. The data are presented as fold changes in obese
compared to lean subjects. Non-parametric Mann–Whitney test was used for statistical analysis.
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protein expression levels using IHC (data not shown).
Modulation of the heat shock response by physical
exercise
Physical exercise is becoming the first line non-
pharmacologic choice for the prevention and manage-
ment for obesity and its complications. This prompted
us to investigate the effects of physical exercise on the
expression levels of HSPs. We previously reported that
our 3-month physical exercise protocol that while it had
no significant effect on improving the BMI of obese sub-
jects, it reduced significantly the PBF and SBP an in-
creased the maximal oxygen consumption as reflected
by the VO2 Max [31]. Physical exercise was also associ-
ated with a reduction in the inflammatory response as
indicated by reduced levels of IL-6, TNF-α and MCP-1
aside with clear decrease in TBARS and increase in ROS[31]. In the adipose tissue, the endogenous expression
of IL-6 and TNF-α was significantly reduced in obese
subjects by physical exercise (Figure 4A and B). The ex-
pression of RANTES and its CCR5 receptor were also
attenuated by physical exercise in obese subjects [32].
To investigate whether physical exercise had an impact
on the expression of HSPs, adipose tissue collected from
obese before and after the exercise program was ana-
lyzed by IHC. As shown in Figure 5A, our physical exer-
cise protocol restored the normal expression of the
HSPs tested to levels comparable to lean control group.
Indeed, the levels of HSP-60, HSP-72, HSP-90 and GRP-
94 proteins were all significantly decreased by physical
exercise (P < 0.05), while the expression of DNAJB3 was
significantly induced by physical exercise (Figure 5A).
This effect of physical exercise on HSPs expression in
obese subjects was also confirmed at the level of mRNA
from PBMCs (Figure 5B).
A B
C
Figure 2 Protein and mRNA Expression profiles of components of the HSR in non-diabetic obese subjects. (A) Representative slides of
HSPs and chaperone expression levels using IHC and the subcutaneous adipose tissue from lean and obese participants (n = 10 for each group).
Aperio software was used to quantify positive staining from lean and obese participants as detailed in Material and Methods. (B) Representative
Western blots of lean and obese subjects showing the expression pattern of various HSPs and chaperones. Total proteins were extracted from
PBMCs of lean and obese participants (n = 9 for each group) and detected using the indicated antibodies. The blots shown are representative of
3 experiments with consistent results. Densitometric quantification of the Western blots data. The bands of interest were quantified as described
in materials and methods and the relative intensities were determined after correction with Actin. (C) Quantitative analysis of HSPs mRNA in lean
and obese subjects using PBMCs (n = 9 for each group). Total mRNA was isolated and subjected to analysis using qRT-PCR. The quantified data
are presented as fold changes in obese compared to lean subjects. Non-parametric Mann–Whitney test was used for statistical analysis.
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Dysregulation of the heat shock response is a crucial
event that leads to diabetes through the development of
insulin resistance. However, the contribution of obesity to
this dysregulation in humans has not yet been investi-
gated. In the current study, we profiled the expression pat-
tern of various components of the heat shock response inlean and obese subjects and established the possible corre-
lations with various physical, clinical and biochemical pa-
rameters of the study population. We also investigated
whether physical exercise could restore the expression of
proteins showing differential expression between lean and
obese subjects. The main findings of this investigation are:
1) obesity increased significantly the expression of the
A B C D
E F G H
I J K L
Figure 3 Correlation analysis. DNAJB3 (A-D), HSP-72 (E-H) and GRP-94 (I-L) expression levels in adipose tissue, as quantified using IHC staining,
were correlated with BMI, PBF, IP-10 and RANTES. Correlations were assessed using Spearman’s rank correlation coefficient.
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expression of HSP-27 and reduced significantly the ex-
pression of DNAJB3-HSP-40, 2) the expression levels of
HSP-72 in obese subjects are linked to the diabetes status
of the study population, and 3) a 3-months physical ex-
ercise protocol was sufficient to restore the abnormal
expression of HSPs with a concomitant decrease in the
inflammatory response.
To the best of our knowledge, this is the first study
that investigated simultaneous expression of compo-
nents of the HSR in non-diabetic human obese subjects
using adipose tissue as well as evaluating their response
to physical exercise. It is worth noting that the observed
expression pattern of the HSR between lean and obese
subjects was not related to gender as both males and fe-
males have shown the same trend at mRNA and protein
levels (data not shown).
The fact that we observed a similar pattern in the ex-
pression of the HSR in PBMCs and the adipose tissue
indicate that HSR dysregulation is not only limited to
the subcutaneous adipose tissue and thus PBMCs could
be an interesting surrogate target for follow up studiesto understand the mechanisms leading to dysregulated
expression of the HSR by obesity.
It is well established that in obesity, the uncontrolled
inflammatory reaction and impairment of the host
defense system, plays an important role in the inhibition
of insulin receptor signaling cascade and as a direct con-
sequence, disruption of systemic metabolic homeostasis
that leads to T2D [33]. Recently, it was proposed that
T2D is the result of a metabolic paradigm in which
metabolic inflammation; insulin resistance and impair-
ment of the HSR work in a vicious cycle [34,35]. Our
findings that investigated the sole contribution of obesity
on the status of the heat shock response indicate that
the defect in HSR observed previously in obesity-induced
insulin resistance and diabetes [5,6,18] is more complex
than what was initially thought and it presumably involves
different mechanism of action.
The activation of the HSR is a crucial step required to
maintain normal homeostasis in response to physiological
and patho-physiological damages. It is well known that ex-
posure to a preconditioning stress increases a cell's toler-
ance to subsequent stress, and this effect has been shown
A B
Figure 4 Physical exercise restored IL-6 and TNF-α expression levels in obese subjects. Analysis of IL-6 (A) and TNF-α (B) expression by
IHC using subcutaneous adipose tissue from obese non-diabetic participants before and after exercise (n = 14 each). Aperio software was used to
quantify positive staining (indicated by arrows on the IHC slides) as detailed in Material and Methods section. Quantified data are presented as
fold of change. Paired t-test was used for statistical analysis.
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ticularly HSP-27, HSP-60 and HSP-72 following the pre-
conditioning stress [36]. Increased content of HSPs is
thought to restore cellular homeostasis and remodelling,
and protect against further cellular stress and damage in
vulnerable tissue organs [37,38]. In the context of obesity,
the observed dysregulation of the HSR can be suggested
as a physiological response to alleviate metabolic stress in
key tissue organs such as the adipose tissue and muscles.
It is well established that obesity is associated with activa-
tion of JNK stress kinase [31,39] and enhanced inflamma-
tory response as monitored by the endogenous levels of
IL-6, TNF-α, RANTES and CCR5 receptor in the adipose
tissue [32]. Thus, the up-regulation of the HSPs in obese
subjects is presumably required to mitigate the inflamma-
tory response and to alleviate various forms of metabolic
stress response induced by obesity. It is not however im-
possible that the observed increase in the expression of
HSPs in the current study could be a compensation for re-
duced expression of DNAJB3.Several studies showed that interventions leading to
induction of the HSR or chaperone therapy such as heat
therapy [18,25], transgenic mice or liposomal delivery of
HSPs [18], electrical therapy [26], physical exercise [40]
and pharmacological drugs [27,28] were associated with
beneficial outcomes as monitored by improved glucose
homeostasis, enhanced insulin sensitivity, reduction of
visceral adiposity and suppression of the chronic inflam-
matory state [16,41-43]. Nevertheless, it is worth noting
that most of these studies investigated the status of the
HSR in human and animal models of obesity-induced
insulin resistance and diabetes and they mainly focused
on the expression of HSP-72 and HSP-25/27 in skeletal
muscles. In agreement with those studies, we found that
HSP-72 expression levels in the subcutaneous adipose
tissue were attenuated in a diabetic obese group as com-
pared to non-diabetic obese subjects. In non-diabetics
obese subjects, our data indicated that HSP-72 was in-
creased in obese subjects as compared to lean subjects.
The mechanisms underlying the differential regulation
AB
Figure 5 Physical exercise restored HSPs expression levels in non-diabetic obese subjects. (A) IHC staining using subcutaneous adipose
tissue from obese before and after exercise (n = 10 each). Aperio software was used to quantify positive staining as detailed in Material and
Methods. (B) qRT-PCR analysis of HSPs mRNA in PBMCs from obese subjects before and after exercise (n = 12 each). Quantified data are presented
as fold of change. Paired t-test was used for statistical analysis.
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are still unknown. In line with this, previous studies have
report discrepancy in the expression levels of HSP-72
depending on the tissues [44,45].
Another important aspect that was investigated in the
current study is the effect of physical exercise on the ex-
pression pattern of components of HRS in obese subjects.
Physical exercise is one of the highly recommended strat-
egies to reduce weight and to improve the clinical out-
comes in obese and diabetic patients although the exact
molecular mechanisms underlying these beneficial effects
are not yet well established. Our findings indicated that a
3-month aerobic exercise was sufficient to restore the ex-
pression of the HSR in obese subjects to normal levelsobserved in lean subjects. Under the same conditions, the
endogenous levels of RANTES and its CCR5 receptor
[32], IL-6 and TNF-α in the adipose tissue of obese
subjects were significantly reduced by physical exercise
(Figure 4). It is worth noting that the exercise affected
similarly the expression pattern of the HSR in both male
and female obese subjects (data not shown). Some previ-
ous studies have investigated the effect of a short time
“acute” exercise on the expression of HSPs in males and
females and the results were not consistent. For example,
Gillum et al. [46] reported the effect of a single acute exer-
cise reported that HSP-72 was more increased in men
than women, whereas Njemini et al. [47] reported no dif-
ference in HSP expression between genders. Nevertheless,
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gender-linked effect of long-term exercise on the expres-
sion of HSP in human.
Our current findings are however contrasting previous
studies that reported increased expression of HSPs by
physical exercise [6,18,38,41,48]. One of the possible rea-
sons for this discrepancy is that these investigations fo-
cused on acute effect of exercise on transient expression
of HSPs either immediately after [6,18,41,48] or within
7 days of exercise using a single-session exercise [38].
The different behavior of HSPs from the adipose tissue
in our study as compared to those previous studies could
also be due to the non-damaging and long-term nature of
our physical exercise protocol. Indeed, exercise is consid-
ered as a stress factor in particular when it is intensive
and the type of exercise strongly influences the levels of
circulating HSp-72 (eHSP-72) in blood for example [49].
For instance, in treadmill or downhill running aerobic
exercise increased several times both cellular HSP-72
and blood eHSP-72 during and immediately after exer-
cise [50,51]. In contrast, elbow flexion eccentric exercise
doesn’t increase eHSP-72 [52]. The transient increase in
HSPs could be assigned to the elevation of temperature
in the tissues during exercise as temperature is critical
for the activation of HSR in exercising mammals
[53-55]. As the adipose tissue, in particular the subcuta-
neous one, is superficial and has less vascularisation, its
temperature increase will be limited compared to other
organs. For example the temperature of muscles and
core body at the end of 45 min moderate treadmill exer-
cise exceeded 39°C [38]. Thus, the observed elevated
and long-lasting HSP levels in the cells may have better
benefits, as compared to only transient effect, for the
body to cope with the low-grade inflammation charac-
terising obesity. Other authors have already suggested,
in agreement with our current study, that HSP are
expressed and induced by exercise in a tissue-specific
manner [38,56].
In summary, we demonstrated here that obesity trig-
gers differential regulation of various components of the
HSR in obese non-diabetic subjects and a 3-month phys-
ical exercise was sufficient to restore the normal expres-
sion of HSPs in the adipose tissue with concomitant
attenuation in the inflammatory response. This suggests
that the in non-diabetic obese human the body is still
able to cope with the obesity-related cellular stress via
an upregulation of key cytoprotective HSPs in adipose
tissue and PBMCs. Given the well documented decrease
of HSPs in insulin-resistant and diabetic subjects, it
might be interesting to enhance those proteins in non-
diabetic obese and sustain their over-expression to prevent
the development of further metabolic disorders including
diabetes. Further studies are warranted to examine the ex-
pression levels of HSPs in visceral adipose tissue and otherorgans of non-diabetic obese before suggesting precise
biological significance of increased HSPs expression due
to obesity and the beneficial effects of physical exercise.
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